Measuring binding processes at the single-molecule level underpin significant functions in understanding biological events. Single-nanoparticle imaging techniques are providing a new concept for mapping the heterogeneous behaviors and characterizations of individual dynamics such as molecule-molecule interactions. Here, we develop the optical imaging techniques for directly counting and monitoring the binding and motion events of single nanoparticles linked to the substrate via the specific and reversible interactions between biomolecules. The one-step digital immunoassay realizes the biomolecular detection based on dynamic counting of the single nanoparticle binding event to substrate with the bright-field imaging. The detection limit achieves 8.4 pg/mL for procalcitonin with detection time of 14 min. Meanwhile, we map the accurate trajectory of single nanoparticle switching between different target molecules among the plane with the total internal reflection imaging technique, which reveals the spatial coordinates of single target molecules on the substrate surface with high spatial and temporal resolutions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acssensors.0c02184 | DOI Listing |
Psychol Res
January 2025
University of Toronto, Toronto, Canada.
Efficient and flexible responses are essential for successfully interacting with the environment. These interactions require an instantaneous integration of visual stimuli and responses, known as 'stimulus-response binding' (SR binding). SR binding is considered part of a holistic temporary representation, the event file, that integrates the stimulus, the response, and the action effect produced by this response.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Department of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.
Background: Accumulation of amyloid beta in the brain is one of the first events in Alzheimer's disease (AD) and starts decades before symptoms arise. It has been hypothesized that brain areas with higher levels of neuronal activation ('hubs') are more prone to amyloid deposition. In this study, we examined the regional relationship between cortical hubs and longitudinal changes in amyloid pathology in a sample of cognitively healthy older subjects.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Huashan Hospital, Fudan University, Shanghai, Shanghai, China.
Background: Alzheimer's disease (AD) is characterized by the deposition of amyloid plaques and tau neurofibrillary tangles in the brain with continuous cognitive impairment. Although the mechanism underlying AD pathogenesis remains unclear, more evidence suggests that synaptic dysfunction and loss may be an early event in disease progression. Metabotropic glutamate receptor 5 (mGluR5), a kind of G protein-coupled receptor, is involved in AD pathology through modulating synaptic transmission and plasticity and thus exhibits therapeutic effects.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.
Background: Cerebral Aβ accumulates decades before symptom onset in AD. Sampled iterative local approximation (SILA, Betthauser et al. 2022) is a technique for estimating time from Aβ positivity (Aβ+) using Aβ-PET.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Background: TDP-43 nuclear clearance and cytoplasmic aggregation occur in an estimated 30-60% of cases of Alzheimer's disease (AD), but this pathology can currently only be established at autopsy. Nuclear clearance of TDP-43 leads to inclusion of cryptic exons in pre-mRNA, some of which are spliced in-frame and translated into proteins carrying novel cryptic exon-encoded epitopes. We developed a Meso Scale Discovery (MSD) ELISA against the TDP-43-associated cryptic neoepitope within the HDGFL2 protein and found significantly elevated levels of this cryptic neoepitope in biofluids of presymptomatic ALS-FTD (Irwin et al.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!